The very public sharing of Gene Hackman and Betsy Arakawa’s health details raises ethical questions over privacy.
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
It was thought that a transplant would be the only option for Tomas, until he was enrolled on to the groundbreaking gene therapy trial at Great Ormond Street Hospital (GOSH) in London. Symptoms of the ...
A study of a woman who died in 2024 as the oldest person on Earth attempts to untangle the factors that enable some people to ...
Research shows a small group of participants in an Alzheimer’s study experienced a significant delay in the onset of symptoms ...
Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...
The people involved in the study have rare genetic mutations, making it nearly certain they will develop Alzheimer's. AP reports on how mass firings and funding restrictions at the NIH are affecting ...
The bill currently going through the committee process in the Tennessee General Assembly, would pay family caregivers with TennCare funds.
Fostering dialogue between neurologists, researchers, patient representatives, and policymakers is an important step towards ...
The Maryland Terrapins have a secret weapon. Her name is Sophie Rupolo. She’s 16 years old and — despite a rare genetic ...
Patients with Fuchs endothelial corneal dystrophy with particular genetic markers are at higher risk for surgery and vision loss.
Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results